SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-020287
Filing Date
2020-02-13
Accepted
2020-02-13 17:04:19
Documents
1
Period of Report
2020-02-09
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm207930-1_8k.htm 8-K 39619
  Complete submission text file 0001104659-20-020287.txt   41078
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 20611822
SIC: 2834 Pharmaceutical Preparations